

Please try another search
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Name | Age | Since | Title |
---|---|---|---|
David C. Hodgson | 67 | 2022 | Independent Director |
Henry A. Fernandez | 66 | 2020 | Lead Independent Director |
Gregory Norden | 66 | 2020 | Independent Director |
Ted W. Love | 65 | 2020 | Independent Director |
Catherine M. Engelbert | 59 | 2020 | Independent Director |
Errol B. De Souza | 71 | 2020 | Independent Director |
Vladimir Coric | 54 | 2025 | Director |
Pablo Gerardo Legorreta | 60 | 1996 | Founder, Chairman of the Board & CEO |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review